Search Count: 59
 |
Influenza A Virus Nucleoprotein(8-498)Np Complex With 5-(4-{[(2R)-6,6-Dimethyl-1,4-Dioxan-2-Yl]Methoxy}Phenyl)-2-Oxo-6-(Trifluoromethyl)-1,2-Dihydropyridine-3-Carboxamide (Compound 13)
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2025-08-06 Classification: VIRAL PROTEIN Ligands: A1CEF, MG |
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION
Release Date: 2025-08-06
Ligands: A1CEF, MG
 |
Influenza A Virus Nucleoprotein(8-498)Np Complex With 5-(4-(Morpholinomethyl)Phenyl)-2-Oxo-6-(Trifluoromethyl)-1,2-Dihydropyridine-3-Carboxamide (Compound 3)
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2025-08-06 Classification: VIRAL PROTEIN Ligands: A1CEM, MG |
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION
Release Date: 2025-08-06
Ligands: A1CEM, MG
 |
Influenza A Virus Nucleoprotein(8-498)Np Complex With Rac-5-(4-(((2R,6R)-6-(Methoxymethyl)-6-Methyl-1,4-Dioxan-2-Yl)Methoxy)Phenyl)-2-Oxo-6-(Trifluoromethyl)-1,2-Dihydropyridine-3-Carboxamide (Compound 20)
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION Resolution:2.33 Å Release Date: 2025-08-06 Classification: VIRAL PROTEIN Ligands: A1CEO |
Organism: Influenza a virus (a/(puerto rico/8/1934-korea/426/1968)(h2n2))
Method: X-RAY DIFFRACTION
Release Date: 2025-08-06
Ligands: A1CEO
 |
Crystal Structure Of Engineered Ipilimumab (Mipi.4) Fab In Complex With Human Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-02-05
 |
Crystal Structure Of Engineered Ipilimumab (Mipi.4) Fab In Complex With Mouse Ctla-4
Organism: Mus musculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
Organism: Mus musculus, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-02-05
 |
Crystal Structure Of Anti-Ctla-4 Fab (9D9) In Complex With Mouse Ctla-4
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2025-02-05
 |
Crystal Structure Of Heterotrimeric Anti-Tigit Fabs In Complex With Human Tigit
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2023-09-20 Classification: IMMUNE SYSTEM,PROTEIN BINDING Ligands: NAG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-09-20
Ligands: NAG
 |
Hucaspase-6 In Complex With Inhibitor 3A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2023-05-10 Classification: APOPTOSIS,HYDROLASE/INHIBITOR Ligands: UCI, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-05-10
Ligands: UCI, EDO
 |
Hucaspase-6 In Complex With Inhibitor 2A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2023-05-10 Classification: APOPTOSIS,HYDROLASE/INHIBITOR Ligands: CL, EDO, US9, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-05-10
Ligands: CL, EDO, US9, PEG
 |
Crystal Structure Of Fab In Complex With Mica Alpha3 Domain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2022-10-05 Classification: IMMUNE SYSTEM Ligands: NAG, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-10-05
Ligands: NAG, EDO
 |
Crystal Structure Of An Acidic Ph-Selective Ipilimumab Variant Ipi.105 In Complex With Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2022-03-02 Classification: IMMUNE SYSTEM Ligands: NAG, FLC, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
Ligands: NAG, FLC, PEG
 |
Crystal Structure Of An Acidic Ph-Selective Ipilimumab Variant Ipi.106 In Complex With Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2022-03-02 Classification: IMMUNE SYSTEM Ligands: NAG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
Ligands: NAG
 |
Crystal Structure Of Fab In Complex With Mouse Cd96 Monomer
Organism: Mus musculus, Rattus
Method: X-RAY DIFFRACTION Resolution:2.58 Å Release Date: 2021-11-03 Classification: IMMUNE SYSTEM Ligands: NAG, SO4 |
Organism: Mus musculus, Rattus
Method: X-RAY DIFFRACTION
Release Date: 2021-11-03
Ligands: NAG, SO4
 |
Crystal Structure Of Fab In Complex With Mouse Cd96 Dimer
Organism: Rattus, Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2021-10-20 Classification: IMMUNE SYSTEM Ligands: EDO, FLC, NAG |
Organism: Rattus, Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2021-10-20
Ligands: EDO, FLC, NAG
 |
E.Coli Lpxa In Complex With Compound 1
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-03-11 Classification: TRANSFERASE/INHIBITOR Ligands: PO4, DMS, O5J |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2020-03-11
Ligands: PO4, DMS, O5J
 |
E.Coli Lpxa In Complex With Udp-3-O-(R-3-Hydroxymyristoyl)-Glcnac And Compound 2
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2020-03-11 Classification: TRANSFERASE/INHIBITOR Ligands: U20, PO4, DMS, O5P |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2020-03-11
Ligands: U20, PO4, DMS, O5P
 |
E.Coli Lpxa In Complex With Udp-3-O-(R-3-Hydroxymyristoyl)-Glcnac And Compound 6
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2020-03-11 Classification: TRANSFERASE/INHIBITOR Ligands: U20, PO4, DMS, O5M |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2020-03-11
Ligands: U20, PO4, DMS, O5M
 |
E.Coli Lpxa In Complex With Udp-3-O-(R-3-Hydroxymyristoyl)-Glcnac And Compound 7
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2020-03-11 Classification: TRANSFERASE/INHIBITOR Ligands: U20, PO4, DMS, O5G |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2020-03-11
Ligands: U20, PO4, DMS, O5G
 |
E.Coli Lpxa In Complex With Udp-3-O-(R-3-Hydroxymyristoyl)-Glcnac And Compound 8
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2020-03-11 Classification: TRANSFERASE/INHIBITOR Ligands: U20, PO4, DMS, O5D |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2020-03-11
Ligands: U20, PO4, DMS, O5D
 |
Chain A. Udp-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase Pa-Lpxc Complexed With (R)-3-((S)-3-(4-(Cyclopropylethynyl)Phenyl)-2-Oxooxazolidin-5-Yl)-N-Hydroxy-2-Methyl-2-(Methylsulfonyl)Propenamide
Organism: Pseudomonas aeruginosa (strain atcc 15692 / dsm 22644 / cip 104116 / jcm 14847 / lmg 12228 / 1c / prs 101 / pao1)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-01-23 Classification: HYDROLASE Ligands: JBA, ZN |